ZURICH (Reuters) - Switzerland's Novartis AG is cutting prices for its malaria drug Coartem by a fifth to improve access to treatment, especially in Africa, it said on Wednesday.
Novartis said on Wednesday it would reduce prices for the drug from this Friday, which is World Malaria Day, and it was able to supply the drug more cheaply due to efficiency improvements at its production facilities in China and the United States.
